Nanotechnology is a new concept that will soon become the pinnacle of science and technology. It penetrates using nanometer-sized molecules and has demonstrated its worth in space, medicine, and other fields of science. Because the eye is a small organ that can be easily accessed due to its exposed location, it is an ideal target for nanotechnology. It appears that the "discovery of nanomedicines has reawakened huge aspirations for ophthalmic pharmacotherapy, in which nanostructured drugs are predicted to pass through the eye's limiting barriers." Safe manufacturing procedures and unforeseen biological repercussions of nanomaterial use remain barriers to nanotechnology adoption. These challenges are not insurmountable, and this developing sector is likely to yield innovative treatments for ocular disorders.
Purpose: Fundus angiography (FA) imaging is limited by the drawbacks of standard fluorescein dye, including a narrow excitation spectrum, a non-uniform spectral emission pattern, photobleaching, and…
Oral and poster slots for original Nanotechnology in Ophthalmology work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Nanotechnology in Ophthalmology research and practice.
Attend in person in Singapore or join virtually — same program, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Nanotechnology in Ophthalmology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Nanotechnology in Ophthalmology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Nanotechnology in Ophthalmology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Nanotechnology in Ophthalmology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
